The association between vitamin B12, albuminuria and reduced kidney function: an observational cohort study

BMC Nephrology

Caroline S Fox¹  Paul Muntner³  Jacob Selhub²  Paul F Jacques²  Rikki M Tanner³  Shih-Jen Hwang⁴  Gearoid M McMahon⁵ 

[1] Division of Endocrinology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA;USDA Human Nutrition Center on Aging, Tufts University, Boston, MA, USA;Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA;National Heart, Lung and Blood Institute’s Framingham Heart Study and the Center for Population Studies, 73 Mt. Wayte Ave, Suite 2, Framingham, MA 01702, USA;Renal Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

关键词: Reduced kidney function;    Vitamin B12;    Albuminuria;    Homocysteine;   

Others  :  1122055
DOI  :  10.1186/1471-2369-16-7

 received in 2014-06-02, accepted in 2015-01-14,  发布年份 2015

【 摘 要 】

Background

Variants in CUBN, the gene encoding cubilin, a proximal tubular transport protein, have been associated with albuminuria and vitamin B12 (B12) deficiency. We hypothesized that low levels of B12 would be associated with albuminuria in a population-based cohort.

Methods

We analyzed participants from the Framingham Heart Study (n = 2965, mean age 58 years, 53% female) who provided samples for plasma B12. Logistic regression models adjusted for covariates including homocysteine were constructed to test the association between B12 and prevalent albuminuria (UACR ≥17 mg/g [men] and ≥25 mg/g [women]) and reduced kidney function (defined as an eGFR < 60 ml/min/1.73 m², RKF). Because of a significant interaction between B12 and homocysteine in the prevalent RKF model (p = 0.005), the model was stratified by the median homocysteine levels. Logistic regression models were constructed to test the association between B12 and incident albuminuria and RKF. The results were replicated in 4445 participants from NHANES 2003–2004.

Results

Baseline B12 levels ranged from 50-1690 pg/ml. Elevated B12 was associated with prevalent albuminuria (OR 1.44 per 1 SD increase, 95% CI 1.10-1.87) and RKF (OR 1.83, 95% CI 1.30-2.60). However after stratifying by median homocysteine levels, this relationship remained only in the higher homocysteine stratum. There was no association between B12 and incident albuminuria (OR 1.17, 95% CI 0.79 – 1.73) or RKF (OR 1.45, 95% CI 0.97 – 1.88). In the NHANES cohort, elevated B12 was associated with RKF after full covariate adjustment (OR 3.06, 95% CI 2.30-4.08). There was no association with albuminuria.

Conclusion

In participants with high baseline homocysteine levels, increased plasma B12 was associated with RKF.

【 授权许可】

   
2015 McMahon et al.; licensee BioMed Central.

【 参考文献 】

• [1]Storm T, Emma F, Verroust PJ, Hertz JM, Nielsen R, Christensen EI: A patient with cubilin deficiency. N Engl J Med 2011, 364:89-91.
• [2]Pollock CA, Poronnik P: Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr Opin Nephrol Hypertens 2007, 16:359-64.
• [3]Birn H: The kidney in vitamin B12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins. Am J Physiol Renal Physiol 2006, 291:F22-36.
• [4]Grasbeck R: Imerslund-Grasbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). Orphanet J Rare Dis 2006, 1:17. BioMed Central Full Text
• [5]Boger CA, Chen MH, Tin A, Olden M, Kottgen A, de Boer IH, et al.: CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011, 22:555-70.
• [6]Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras MG, Usala G, et al.: Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 2009, 84:477-82.
• [7]Franke B, Vermeulen SH, Steegers-Theunissen RP, Coenen MJ, Schijvenaars MM, Scheffer H, et al.: An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res A Clin Mol Teratol 2009, 85:216-26.
• [8]Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, et al.: The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ 2012, 344:e3533.
• [9]Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979, 110:281-90.
• [10]Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-70.
• [11]Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W: Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I–Folate, Vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med 2010, 23:1323-43.
• [12]Andres E, Serraj K, Zhu J, Vermorken AJ: The pathophysiology of elevated vitamin B12 in clinical practice. QJM 2013, 106(6):505-15.
• [13]Carmel R, Vasireddy H, Aurangzeb I, George K: High serum cobalamin levels in the clinical setting–clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001, 23:365-71.
• [14]Jammal M, Deneuville T, Mario N, Tiev K, Toledano C, Josselin-Mahr L, et al.: High plasmatic concentration of vitamin B12: An indicator of hepatic diseases or tumors. Rev Med Interne 2013, 34(6):337-41.
• [15]Henning BF, Zidek W, Riezler R, Graefe U, Tepel M: Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate. Res Exp Med (Berl) 2001, 200:155-68.
• [16]Ermens AA, Vlasveld LT, Lindemans J: Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003, 36:585-90.
• [17]Qian L, Quadros EV, Regec A, Zittoun J, Rothenberg SP: Congenital transcobalamin II deficiency due to errors in RNA editing. Blood Cells Mol Dis 2002, 28:134-42. discussion 143–5
• [18]Herrmann W, Obeid R, Schorr H, Geisel J: Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003, 41:1478-88.
• [19]Obeid R, Kuhlmann M, Kirsch CM, Herrmann W: Cellular uptake of vitamin B12 in patients with chronic renal failure. Nephron Clin Pract 2005, 99:c42-8.
• [20]Koyama K, Yoshida A, Takeda A, Morozumi K, Fujinami T, Tanaka N: Abnormal cyanide metabolism in uraemic patients. Nephrol Dial Transplant 1997, 12:1622-8.
• [21]Koyama K, Ito A, Yamamoto J, Nishio T, Kajikuri J, Dohi Y, et al.: Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis. Am J Kidney Dis 2010, 55:1069-78.
• [22]House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al.: Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010, 303:1603-9.
• [23]Morris MS, Selhub J, Jacques PF: Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J Am Geriatr Soc 2012, 60:1457-64.
• [24]Stabler SP: Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013, 368:149-60.